Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Mrv (General Partner Meif Ii Equity Em) Limited investment portfolio
Mrv (General Partner Meif Ii Equity Em) Limited has made numerous investments in companies such as Serve First Cx, Neurotherapeutics, and Warehow within the Health Tech sector.
vc
Portfolio
3
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Neurotherapeutics Ltd Neurotherapeutics Ltd, trading as Neupulse, designs and manufactures neurotherapeutic medical devices for clinical trials, targeting neurological conditions such as tic disorders in partnership with NHS trusts and academic research institutions. | Health TechDeepTech | Nottingham | Confirmed | 2026-02-10 |
| Serve First Cx Ltd Serve First CX Ltd provides an AI‑driven customer experience software platform that consolidates reviews, surveys, receipts, audits, mystery‑shopping and sentiment data to deliver real‑time, actionable insights for businesses. Its solution is marketed to multi‑site organisations across sectors such as retail, hospitality, facilities management, health & wellness, franchise and media. | Software & IT | Milton Keynes | Confirmed | 2026-01-13 |
Shareholding changes (3)
Mrv (General Partner Meif Ii Equity Em) Limited's positions across portfolio companies2026
- SEED 1 ORDINARY SHARES 12,664 → 36,349
- ORDINARY A 0 → 360,972
Articles (1)
- Neupulse Secures Latest Seed Funding Round of £213.3k1 May 2026Neurotherapeutics